Venous thromboembolism in a case with pemphigus vulgaris after infusion of rituximab plus systemic glucocorticoids and azathioprine: A possible adverse effect of rituximab?
- 1 January 2021
- journal article
- letter
- Published by Medknow in Dermatologica Sinica
- Vol. 39 (2), 103-+
- https://doi.org/10.4103/ds.ds_7_21
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- The Risk of Thromboembolism Associated with Treatment of ITP with Rituximab: Adverse Event Reported in Two Randomized Controlled TrialsBlood, 2019
- The Risk of Pulmonary Embolism in Patients With Pemphigus: A Population-Based Large-Scale Longitudinal StudyFrontiers in Immunology, 2019
- Acute jugular vein thrombosis during rituximab administration: Review of the literatureJournal of Oncology Pharmacy Practice, 2014
- Intermediate doses of rituximab used as adjuvant therapy in refractory pemphigusIndian Journal of Dermatology, Venereology and Leprology, 2014
- Adjuvant rituximab in the treatment of pemphigus vulgaris: a phase II clinical trialInternational Journal of Dermatology, 2013
- Use of Glucocorticoids and Risk of Venous ThromboembolismJAMA Internal Medicine, 2013
- Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulinsBritish Journal of Dermatology, 2007
- Rituximab in autoimmune bullous diseases: mixed responses and adverse effectsBritish Journal of Dermatology, 2007